2-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)-3,5,6,7-tetrahydro-4H-cyclopenta[d]pyrimidin-4-one, 95.0%, 500mg

1-(1,3-Benzothiazol-2-yl)-1h-pyrrole-2-carbaldehyde, 98%, 1g

((1R,3s,5S)-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl)methanamine hydrochloride, 250mg

(9H-fluoren-9-yl)methyl (4-hydroxybutyl)carbamate, 95%, 1g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-piperidone>98.0%(HPLC)1g

1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,2,2-trichloroethanone, 98%, 100mg

2,5-Dibromotoluene, 98.0%, 500g

5,6,7,8-TETRAHYDROISOQUINOLIN-1-AMINE, 95.0%, 10g

1-(5-methyl-1H-benzimidazol-2-yl)ethanol, 95.0%, 5g

5-Fluoro-8-methoxyquinoline, 98%, 5g

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 100, 4000 ml, 250 mm, 1 Piece

4-(Cyclohexyloxy)benzoic acid, 95+%, 1g

(2-Aminoethyl)(methyl)(propan-2-yl)amine, 95%, 250mg